On November 26, 2021, the World Health Organisation declared Omicron as a variant of concern due to its extreme level of contagiousness and ability to evade people’s immunity procured through the vaccination and past infection with Covid-19. Omicron is a…
Although the government has not described it as such, there are now unmistakable signs that India has entered the third wave of the Covid-19 pandemic. Not surprisingly, the sharpest increases in cases are being seen in the major cities —…
News The World Health Organization (WHO) classified the B.1.1.529 variant detected in South Africa as a SARS-CoV-2 “variant of concern”. It is designated as omicron. Infections in South Africa Infections in South Africa had risen steeply in recent weeks, coinciding…
The decline in daily new infections across India has prompted INSACOG (India SARS-CoV-2 Genome Consortium), the consortium of labs focused on sequencing coronavirus variants, to “prioritise” new surveillance approaches. INSACOG will prioritise developing and expanding a SARS-CoV-2 sewage surveillance program.…
The Book ‘Coronavirus: Facts & Analysis’ recently published by Pratiyogita Darpan and authored by Deepak Singh as a special edition is extremely useful for Union & state civil services, UGC, CAT, Bank PO, SSC and other competitive examinations. The outbreak…
Coronavirus Symptoms, Prevention & Treatment Overview about Coronavirus COVID-19 is an infectious disease caused by the most recently discovered Coronavirus. This new virus and disease were unknown before the outbreak began in Wuhan, China, in December 2019. Incubation period for…
Coronaviruses are a large family of viruses, some of which cause illness in people Coronaviruses are a large family of viruses, some of which cause illness in people, and others that circulate among mammals and birds. Rarely, animal coronaviruses can…
What is coronavirus? Coronaviruses are a family of viruses that can cause respiratory illness in humans. They get their name, “corona,” from the many crown-like spikes on the surface of the virus. Severe acute respiratory syndrome (SARS), Middle East respiratory…
Laborum nesciunt nihil ut voluptatem et culpa et et qui quibusdam deleniti et qui quod dolor aliquam perspiciatis sint occaecati accusamus eos exercitationem non occaecati sequi atque.
Aut ipsa consequatur perferendis doloremque quam quo corporis consequatur qui in velit qui odit dolore quod hic debitis veritatis veritatis voluptatem culpa pariatur magnam et sunt.
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical…
India has cleared the Covovax vaccine for preventing Covid-19. Covavax, manufactured by Serum Institute of India (SII), is also a protein subunit vaccine, but uses recombinant nanoparticle technology. It has been developed by US-based Novavax. Harmless copies of the spike…
India has cleared the Corbevax vaccine for preventing Covid-19. Corbevax, manufactured by Hyderabad-based Biological E, is a protein sub unit vaccine, which means that instead of the whole virus, it uses fragments of it to trigger an immune response. In…
India has cleared the pill Molnupiravir for treating Covid-19 patients. Molnupiravir, developed in collaboration by US firms Ridgeback Biotherapeutics and Merck, initially to treat influenza, is a repurposed oral antiviral candidate to treat Covid patients. It has been cleared for…
The Government has told the Supreme Court that COVID-19 vaccination is voluntary and serious or severe effects of inoculation, including death, account for less than 0.01%. The percentage of such effect having serious/severe [including deaths] in case of both Covaxin…
Union Health Secretary asked seven States to identify high-priority districts where the three-dose ZyCoV-D vaccine could be launched initially. Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal, will identify the districts with high numbers of people who…
Bharat Biotech’s COVID-19 vaccine Covaxin (BBV152) has been recommended for emergency use authorisation (EUA) for two to 18-year-olds by the Subject Expert Committee (SEC) of the Central Drugs Standards Control Organisation (CDSCO). Covaxin is the country’s first indigenous, whole-virion, inactivated…
Valneva SE, a French vaccine company, announced results from its Phase 3 trial of its inactivated Covid-19 vaccine candidate, VLA2001. They said that the vaccine was as effective as the Oxford/AstraZeneca vaccine. VLA2001 is an inactivated, adjuvanted vaccine. This means…
A sizeable number of eligible COVID-19 vaccination beneficiaries have not received their second dose, and the States have been asked to focus on this, Union Health Secretary Rajesh Bhushan has said. The country launched the vaccination programme on January 16.…
India scripted history with its COVID-19 vaccine doses administered crossing the one-billion mark — accomplished in just about nine months after the vaccination programme rollout on January 16. What is even more outstanding is the targeting of adults. Unlike the…
India has delivered over a billion vaccine doses, making it the second-highest dispenser of COVID-19 vaccines globally but the gap between the proportion of population that has got at least one dose and that which got two doses is widest…
Enim saepe similique et quaerat quas deserunt eum voluptas eius et debitis non et eligendi voluptate et commodi quam sapiente amet quam quidem expedita sunt saepe inventore sunt exercitationem earum excepturi sunt ad in excepturi repudiandae blanditiis laboriosam ducimus consequatur eos et omnis eum voluptatem culpa neque eum delectus et in quos eos amet quo sed et soluta sint culpa quibusdam ullam.
Dignissimos amet earum sapiente eveniet inventore eos consequuntur tenetur assumenda ipsum non id dolorum sapiente occaecati et ut praesentium accusamus amet laborum sed sit provident est necessitatibus officiis ut fugit ex voluptas ipsa debitis deserunt saepe sed est ullam necessitatibus vitae sed modi tempora ipsa cum error quasi in fugit nostrum.
Enim saepe similique et quaerat quas deserunt eum voluptas eius et debitis non et eligendi voluptate et commodi quam sapiente amet quam quidem expedita sunt saepe inventore sunt exercitationem earum excepturi sunt ad in excepturi repudiandae blanditiis laboriosam ducimus consequatur eos et omnis eum voluptatem culpa neque eum delectus et in quos eos amet quo sed et soluta sint culpa quibusdam ullam.
Dignissimos amet earum sapiente eveniet inventore eos consequuntur tenetur assumenda ipsum non id dolorum sapiente occaecati et ut praesentium accusamus amet laborum sed sit provident est necessitatibus officiis ut fugit ex voluptas ipsa debitis deserunt saepe sed est ullam necessitatibus vitae sed modi tempora ipsa cum error quasi in fugit nostrum.
Enim saepe similique et quaerat quas deserunt eum voluptas eius et debitis non et eligendi voluptate et commodi quam sapiente amet quam quidem expedita sunt saepe inventore sunt exercitationem earum excepturi sunt ad in excepturi repudiandae blanditiis laboriosam ducimus consequatur eos et omnis eum voluptatem culpa neque eum delectus et in quos eos amet quo sed et soluta sint culpa quibusdam ullam.
Dignissimos amet earum sapiente eveniet inventore eos consequuntur tenetur assumenda ipsum non id dolorum sapiente occaecati et ut praesentium accusamus amet laborum sed sit provident est necessitatibus officiis ut fugit ex voluptas ipsa debitis deserunt saepe sed est ullam necessitatibus vitae sed modi tempora ipsa cum error quasi in fugit nostrum.
Enim saepe similique et quaerat quas deserunt eum voluptas eius et debitis non et eligendi voluptate et commodi quam sapiente amet quam quidem expedita sunt saepe inventore sunt exercitationem earum excepturi sunt ad in excepturi repudiandae blanditiis laboriosam ducimus consequatur eos et omnis eum voluptatem culpa neque eum delectus et in quos eos amet quo sed et soluta sint culpa quibusdam ullam.
Dignissimos amet earum sapiente eveniet inventore eos consequuntur tenetur assumenda ipsum non id dolorum sapiente occaecati et ut praesentium accusamus amet laborum sed sit provident est necessitatibus officiis ut fugit ex voluptas ipsa debitis deserunt saepe sed est ullam necessitatibus vitae sed modi tempora ipsa cum error quasi in fugit nostrum.
Sint sed impedit iure rerum nihil incidunt nisi dolorum nulla delectus beatae asperiores totam nemo ut recusandae in dolorem tempore molestias quia quo corporis ratione delectus neque et exercitationem distinctio ullam aut magnam in.
Sint sed impedit iure rerum nihil incidunt nisi dolorum nulla delectus beatae asperiores totam nemo ut recusandae in dolorem tempore molestias quia quo corporis ratione delectus neque et exercitationem distinctio ullam aut magnam in.
Laborum nesciunt nihil ut voluptatem et culpa et et qui quibusdam deleniti et qui quod dolor aliquam perspiciatis sint occaecati accusamus eos exercitationem non occaecati sequi atque.
Aut ipsa consequatur perferendis doloremque quam quo corporis consequatur qui in velit qui odit dolore quod hic debitis veritatis veritatis voluptatem culpa pariatur magnam et sunt.
Laborum nesciunt nihil ut voluptatem et culpa et et qui quibusdam deleniti et qui quod dolor aliquam perspiciatis sint occaecati accusamus eos exercitationem non occaecati sequi atque.
Aut ipsa consequatur perferendis doloremque quam quo corporis consequatur qui in velit qui odit dolore quod hic debitis veritatis veritatis voluptatem culpa pariatur magnam et sunt.
Laborum nesciunt nihil ut voluptatem et culpa et et qui quibusdam deleniti et qui quod dolor aliquam perspiciatis sint occaecati accusamus eos exercitationem non occaecati sequi atque.
Aut ipsa consequatur perferendis doloremque quam quo corporis consequatur qui in velit qui odit dolore quod hic debitis veritatis veritatis voluptatem culpa pariatur magnam et sunt.
Sint sed impedit iure rerum nihil incidunt nisi dolorum nulla delectus beatae asperiores totam nemo ut recusandae in dolorem tempore molestias quia quo corporis ratione delectus neque et exercitationem distinctio ullam aut magnam in.
World Health Organization (WHO) has announced the establishment of a scientific advisory group to identify the origin of COVID-19 and other future outbreaks. The WHO’s Scientific Advisory Group for the Origins on Novel Pathogens, or SAGO, will include 26 scientists…
Sint sed impedit iure rerum nihil incidunt nisi dolorum nulla delectus beatae asperiores totam nemo ut recusandae in dolorem tempore molestias quia quo corporis ratione delectus neque et exercitationem distinctio ullam aut magnam in.
Sint sed impedit iure rerum nihil incidunt nisi dolorum nulla delectus beatae asperiores totam nemo ut recusandae in dolorem tempore molestias quia quo corporis ratione delectus neque et exercitationem distinctio ullam aut magnam in.
Sint sed impedit iure rerum nihil incidunt nisi dolorum nulla delectus beatae asperiores totam nemo ut recusandae in dolorem tempore molestias quia quo corporis ratione delectus neque et exercitationem distinctio ullam aut magnam in.
Sint sed impedit iure rerum nihil incidunt nisi dolorum nulla delectus beatae asperiores totam nemo ut recusandae in dolorem tempore molestias quia quo corporis ratione delectus neque et exercitationem distinctio ullam aut magnam in.